Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 11:37AM ET
4.48
Dollar change
+0.38
Percentage change
9.17
%
Index- P/E- EPS (ttm)-0.14 Insider Own6.92% Shs Outstand89.97M Perf Week2.19%
Market Cap402.69M Forward P/E- EPS next Y-0.30 Insider Trans-1.19% Shs Float83.74M Perf Month22.62%
Income-7.87M PEG- EPS next Q-0.08 Inst Own26.45% Short Float2.77% Perf Quarter122.68%
Sales50.58M P/S7.96 EPS this Y-187.91% Inst Trans-3.64% Short Ratio1.17 Perf Half Y194.46%
Book/sh-1.55 P/B- EPS next Y18.51% ROA-13.75% Short Interest2.32M Perf Year399.42%
Cash/sh0.27 P/C16.87 EPS next 5Y- ROE- 52W Range0.82 - 6.23 Perf YTD121.57%
Dividend Est.- P/FCF- EPS past 5Y46.61% ROI- 52W High-28.16% Beta2.85
Dividend TTM- Quick Ratio1.87 Sales past 5Y-4.81% Gross Margin58.82% 52W Low444.77% ATR (14)0.49
Dividend Ex-Date- Current Ratio2.24 EPS Y/Y TTM90.71% Oper. Margin-29.86% RSI (14)52.89 Volatility7.64% 14.09%
Employees135 Debt/Eq- Sales Y/Y TTM6.09% Profit Margin-15.56% Recom1.14 Target Price8.86
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q47.86% Payout- Rel Volume2.24 Prev Close4.10
Sales Surprise13.26% EPS Surprise-41.18% Sales Q/Q23.63% EarningsMar 05 AMC Avg Volume1.97M Price4.48
SMA20-5.92% SMA5028.24% SMA200101.04% Trades Volume1,585,555 Change9.17%
Date Action Analyst Rating Change Price Target Change
TodayInitiated Raymond James Outperform $7
Apr-07-21Resumed RBC Capital Mkts Outperform $7
Apr-22-19Initiated H.C. Wainwright Buy
Jan-03-19Initiated Lake Street Buy $14
Aug-20-18Initiated RBC Capital Mkts Outperform $23
Aug-20-18Initiated JMP Securities Mkt Outperform $29
Mar-25-24 08:00AM
Mar-22-24 06:00PM
Mar-20-24 08:46AM
Mar-19-24 09:49PM
05:00PM
04:01PM Loading…
04:01PM
Mar-18-24 11:47AM
06:46AM
Mar-15-24 01:00PM
Mar-14-24 05:23PM
Mar-12-24 05:00PM
Mar-07-24 01:43PM
11:56AM
12:53AM
Mar-05-24 10:51PM
06:15PM Loading…
06:15PM
05:15PM
05:05PM
Mar-04-24 09:30AM
Feb-29-24 06:00PM
Feb-21-24 10:27AM
08:00AM
Feb-20-24 06:00PM
Feb-15-24 08:00AM
Feb-14-24 06:00PM
Feb-08-24 06:00PM
Feb-02-24 06:00PM
Jan-30-24 08:00AM
Jan-26-24 06:00PM
Jan-23-24 06:15PM
06:15PM Loading…
Jan-17-24 06:15PM
Jan-11-24 06:15PM
Jan-03-24 08:10AM
Dec-29-23 09:40AM
Dec-13-23 09:40AM
Dec-05-23 08:00AM
Nov-29-23 09:55AM
Nov-27-23 12:00PM
09:40AM
Nov-16-23 12:00PM
Nov-10-23 09:40AM
08:00AM
Nov-08-23 02:58PM
Nov-06-23 05:55PM
05:54PM
04:37PM
Nov-02-23 08:00AM
Nov-01-23 06:00PM
Oct-31-23 08:00AM
Oct-24-23 06:00PM
Oct-09-23 06:15PM
08:00AM
Oct-03-23 06:15PM
Sep-27-23 06:15PM
Sep-21-23 12:24PM
Sep-20-23 09:04AM
Sep-15-23 06:00PM
Sep-13-23 06:15PM
Sep-12-23 08:26AM
Sep-11-23 08:00AM
Aug-23-23 08:00AM
Aug-11-23 07:08AM
Aug-10-23 10:03AM
Aug-07-23 05:40PM
04:38PM
04:01PM
Aug-02-23 08:00AM
Jul-27-23 07:00AM
Jul-25-23 04:01PM
08:00AM
Jul-21-23 06:00PM
Jul-18-23 06:15PM
Jul-14-23 09:40AM
Jul-12-23 06:15PM
Jul-06-23 08:00AM
Jun-29-23 09:35AM
08:42AM
Jun-28-23 09:40AM
Jun-20-23 07:14PM
Jun-14-23 08:00AM
Jun-12-23 09:40AM
May-31-23 08:00AM
May-26-23 09:40AM
May-11-23 12:00PM
May-09-23 10:00AM
May-04-23 06:17AM
May-02-23 06:15PM
05:13PM
04:31PM
Apr-26-23 10:02AM
08:00AM
Apr-25-23 10:01AM
Apr-20-23 08:00AM
Apr-18-23 08:00AM
Apr-17-23 07:18AM
Mar-29-23 08:30AM
Mar-08-23 11:43PM
Mar-07-23 05:15PM
04:01PM
Mar-01-23 10:00AM
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients' therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schobel Alexander MarkChief Innovation/Tech OfficerMar 15 '24Sale6.0050,000300,000984,476Mar 19 02:30 PM
Schobel Alexander MarkChief Innovation/Tech OfficerMar 08 '24Sale5.1925,000129,6851,040,371Mar 12 01:45 PM